SARS-CoV-2 Variant is Strongly Associated with Peak Viral Load and Shedding Duration with Minimal Impact from Host Factors: Results from the CoVPN 5001 Study
William O. Hahn(University of Washington), Ollivier Hyrien(Fred Hutch Cancer Center), Javier R. Lama(Asociación Civil Impacta Salud y Educación), Maphoshane Nchabeleng(Sefako Makgatho Health Sciences University), Hong‐Van Tieu(New York Blood Center), Valeria D Cantos(Emory University), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Craig Innes(Aurum Institute), Leigh H. Fisher(Fred Hutch Cancer Center), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Wadzanai Samaneka(University of Zimbabwe), Pavitra Roychoudhury(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lameck Chinula(University of North Carolina at Chapel Hill), Lynda Stranix‐Chibanda(University of Zimbabwe), Nadine Rouphael(Emory University), Chishiba Kabengele, Catherine Yen(National Institutes of Health), Nicole Espy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brenda Hoagland(Fundação Oswaldo Cruz), Pedro Cahn(Hospital San Juan de Dios), Lawrence Corey(Fred Hutch Cancer Center), Alexander L. Greninger(University of Washington), William Brumskine(Aurum Institute), Khatija Ahmed(University of California, San Francisco), Edgar García, Roma Chilengi(National Institute of Public Administration), Marcelo Losso(UCLA Medical Center), Mmatsie Manentsa, Shannon Grant(Fred Hutch Cancer Center), Colleen F. Kelley(Emory University), Carole L. Wallis, Xiaohong Li(Central South University), Jorge Pinto(Universidade Federal de Minas Gerais), Amy Ward(Wellcome Centre for Infectious Diseases Research in Africa), Joseph Makhema(University of Namur), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shelly Ramirez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Muchaneta Bhondai-Mhuri, Jorge A. Gallardo-Cartagena(National University of San Marcos)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k